Content on PharmTech.com this week ranged from fundamentals on the use of digital pathology in drug development, discussions on the use of AI in pharma, and regulatory actions impacting the industry.
News|Articles|May 29, 2014
PTSM: Pharmaceutical Technology Sourcing and Management
- PTSM: Pharmaceutical Technology Sourcing and Management-06-04-2014
- Volume 10
- Issue 6
DPx Holdings B.V. Donates to Hospitals and Organizations
Author(s)Pharmaceutical Technology Editors
DPx Holdings B.V. donated $110,000 to more than 20 different hospitals and organizations across the globe.
Advertisement
DPx Holdings B.V. was formed earlier this year as a result of a merger between Patheon and DSM Pharmaceutical Products. The company is comprised of three core business units, Patheon Pharma Services, DSM Fine Chemicals, and Banner Life Sciences.
The $5,000 donations were made on behalf of each site to thank employees for their efforts to help improve the lives of patients. Each site selected a local hospital or organization that makes a direct impact on patients in the community.
Source:
Articles in this issue
over 12 years ago
India Offers Biopharma Opportunities and Challengesover 12 years ago
Are CMOs Out of Synch With Market Realities?over 12 years ago
Key Considerations for Quality-Technical Agreementsover 12 years ago
Defining Quality Metrics to Ease Drug Shortagesover 12 years ago
Cocrystals: Industry Takes a Wait-and-See Approachover 12 years ago
DCAT Sharp Sourcing Addresses Procurement Topicsover 12 years ago
FDA Expands CERSI Networkover 12 years ago
HPAPIs: Fast-growing Segment Presents Challenges and Opportunitiesover 12 years ago
Turkish Pharma Manufacturers Look to New Marketsover 12 years ago
Lilly Oncology On Canvas Celebrates 10 Years of Cancer JourneysAdvertisement
Related to this article
This article discusses risk-based lifecycle governance, system implementation considerations, and the progression of batch record control from paper-based to fully electronic systems.
Ronald Piervincenzi, USP, explains why manufacturers should act now and how benchmarking could reward reliable generic drug suppliers.
The FDA approves Lilly's once-weekly insulin efsitora for type 2 diabetes, raising Fc-fusion manufacturing, high-concentration pen, and capacity questions.
Florin Muraru, Gourav Pandey, and Richard Jaenisch explain where human sign-off belongs as multi-agent AI and document-parsing models reach GxP.
In this episode of Ask the Expert, Siegfried Schmitt, PhD, vice president, Technical at Parexel, and Susan J. Schniepp, distinguished fellow at Nelson Labs, discuss how companies should approach post-approval changes to their CMC regulatory filings.
The EC has approved AstraZeneca's Trixeo Aerosphere as the first single-inhaler triple-combination therapy for asthma in the EU, based on phase e data showing improved lung function and fewer severe exacerbations in patients uncontrolled on standard ICS/LABA treatment.
In this episode of Pharma Fundamentals, Dr. Aleksandra Zuraw, senior veterinary pathologist at Charles River, provides an introduction to the use of digital pathology in drug development.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Risk-Based Life Cycle Management of Master Production and Control Records to Strengthen Data Integrity and GMP Inspection Readiness Part 2: Practical Considerations for CGMP Documentation Systems
2
The FDA Finalizes Rule Recognizing Non-Animal Testing Methods, Building on Year-Long Reduction Push
3
EU Clears AstraZeneca's Trixeo for Asthma, Opening New Manufacturing Demand for Single-Inhaler Triple Therapy
4
PharmTech AI Pulse Check: Validating Multi-Agent Systems, OCR Models in GxP
5